1 |
Naess H, Kurtz M, Thomassen L, et al. Serial NIHSS scores in patients with acute cerebral infarction[J]. Acta Neuron Scand, 2016, 133(6): 415-420.
|
2 |
Hori YS, Kodera S, Sato Y, et al. Eosinopenia as a predictive factor of the short-term risk of mortality and infection after acute cerebral infarction[J]. J Stroke Cerebrovasc Dis, 2016, 25(6): 1307-1312.
|
3 |
卢 洁,张金萍,张银萍. 脑梗死合并肺部感染气管切开的护理体会[J]. 西南国防医药,2015, 25(4): 430-431.
|
4 |
郭遂怀,周志鸿. 血必净注射液治疗脑梗死合并肺部感染疗效分析[J]. 中西医结合心脑血管病杂志,2016, 14(1): 86-88.
|
5 |
贺春晖,李 霞,赵懿清,等. 急性脑梗死合并肺部感染患者的病例分析[J]. 中国药物应用与监测,2016, 13(3): 186-188.
|
6 |
Kanbayashi T, Uchida Y, Hokkoku K, et al. Right parietal cerebral infarction with symptoms challenging to differentiate between alien hand sign and sensory ataxia: a case report[J]. Rinsho Shinkeigaku, 2018, 58(5): 568-572.
|
7 |
Xia M, Ye Z, Shi Y, et al. Curcumin improves diabetes mellitus associate cerebral infarction by increasing the expression of GLUT1 and GLUT3[J]. Mol Med Rep, 2018, 17(1): 1963-1970.
|
8 |
Wang YY, Zhang JF, Jiang YB. Prognosis of neutrophil and lymphocyte ratios in patients with acute cerebral infarction with thrombolytic therapy[J]. J Jinan Univer, 2018, 35(4): 1012-1015.
|
9 |
Liang Y, Chen J, Zheng X, et al. Ultrasound-mediated kallidinogenase-loaded microbubble targeted therapy for acute cerebral infarction[J]. J Stroke Cerebrovasc Dis, 2018, 27(3): 867-873.
|
10 |
Peng W, Yang ZQ, Zhou YT. Clinical analysis of Cerebral Infarction Complicated with Pulmonary Infection[J]. China J Pharmaceutical Economics, 2014, 79(2): 143-152.
|
11 |
齐晓涟,郝文婷. 临床药师参与会诊的脑梗死合并肺部感染老年患者抗感染用药分析[J]. 中国药师,2017, 20(7): 1246-1249.
|
12 |
宋晓明,郑珍婕,苏立静,等. 重症脑梗死患者肺部感染的危险因素及病原学分析[J]. 中华医院感染学杂志,2017, 27(9): 1979-1982.
|
13 |
刘晓兰. ICU脑外伤及脑血管病合并肺部感染的病原分布及耐药性分析[J]. 基因组学与应用生物学,2016, 35(10): 2586-2591.
|
14 |
郭晓婷,王秀琼,李雅琴,等. 脑梗死患者合并肺部感染相关因素及护理对策[J]. 中华医院感染学杂志,2018, 51(4): 602-605.
|
15 |
吴晶晶,俞美萍,韦爱华,等. 脑梗死患者肺部感染病原学特点及相关因素分析[J]. 中华医院感染学杂志,2018, 71(3): 348-351.
|